Trial Profile
Effect of Golimumab on Inhibition of Large Joint Destruction in Patients with Rheumatoid Arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2016
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 03 Sep 2016 New trial record